Pharmacy Education 2026

Annie McKee is a sought-after advisor to leaders of Fortune 500 companies, governments and NGOs around the globe. She has co-authored groundbreaking Harvard Business Review books on the power of emotional intelligence to change how we lead and engage with one another. A Senior Fellow at the University of Pennsylvania, Dr. McKee teaches and leads the PennCLO Executive Doctoral Program and the Penn MedEd Master’s program, as well as teaching at the Wharton School’s Aresty Institute of Executive Education. Dr. McKee’s book, How to be Happy at Work: The Power of Purpose, Hope and Friendship delivers a hands-on guide with practical exercises and instructions for how to be happy at work—no matter what job you have.

Dr. Jenkins joined the FDA Office of Women’s Health (OWH) in 2015. In her role as OWH director of medical initiatives and scientific engagement, Dr. Jenkins provides sex and gender science expertise within research, health education, and communications programs.

Dr. Sleeper joined the TTUHSC SOP faculty in 1999 and is currently a professor of pharmacy practice in the geriatrics division and is the associate dean of curriculum for the school. At the Health Sciences Center level she also serves as the vice chair for the TTUHSC Institutional Review Board, and is a member of the TTUHSC Sex and Gender Specific Health program.

Dr. Madras is a professor of psychobiology at Harvard Medical School (HMS), and with a cross-appointment at the Massachusetts General Hospital in Boston. As an HMS faculty member and neuroscientist for 30 years, her research on psychoactive or therapeutic drugs, brain imaging, and others is published in more than 200 manuscripts, articles, books, book chapters and commentaries. On a national level, she currently serves as a key member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

Rita Gunther McGrath is a best-selling author, a sought-after speaker, and a longtime professor at Columbia Business School. She is widely recognized as a premier expert on leading innovation and growth during times of uncertainty. Rita has received the #1 achievement award for strategy from the prestigious Thinkers50 and has been consistently named one of the world’s Top 10 management thinkers in its bi-annual ranking. As a consultant to CEOs, her work has had a lasting impact on the strategy and growth programs of Fortune 500 companies worldwide. Rita is the author of the best-selling The End of Competitive Advantage (Harvard Business Review Press, 2013). Her new book is Seeing Around Corners: How to Spot Inflection Points in Business Before They Happen (Houghton Mifflin Harcourt, 2019). She has written three other books, including Discovery Driven Growth, cited by Clayton Christensen as creating one of the most important management ideas ever developed. She is a highly sought-after speaker at exclusive corporate events around the globe, such as the Global Peter Drucker Forum. She received her Ph.D. from the Wharton School (University of Pennsylvania) and has degrees with honors from Barnard College and the Columbia School of International and Public Affairs.

Dr. Craig D. Cox is a professor of pharmacy practice and division head for adult medicine. He is also the vice chair of experiential programs at Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy (TTUHSC SOP) in Lubbock, Texas, where he has been on faculty for 20 years. He received his Pharm.D. from Washington State University and completed a critical care residency at TTUHSC SOP in Amarillo. Dr. Cox provides clinical pharmacy services on the adult medicine ward at University Medical Center. He has served as the preceptor for more than 400 students and residents on six-week rotations. He has been elected to national leadership positions with the American Association of Colleges of Pharmacy (AACP), including chair of Experiential Education Section, chair of Council of Sections, and chair of Council of Faculties. Each leadership role consisted of a three-year term, with Dr. Cox spending six years on the Board of Directors. Dr. Cox has co-led numerous AACP institutes focused on experiential education both in the United States and abroad. He has participated in multiple strategic planning initiatives with AACP, led development of the annual Teacher’s Seminar focused on diversity and inclusion, and chaired the association-wide programming committee that led to major changes to the program selection process. Dr. Cox has a passion in self-discovery and team development. More recently he has led the rollout of the EQi-2.0 (emotional assessment) to all faculty, students, and staff at the School of Pharmacy, while serving as a consultant for other health profession programs at his institution.

Dr. Anandi V. Law is professor in the Department of Pharmacy Practice and Administration and associate dean for assessment in the College of Pharmacy at Western University of Health Sciences. Dr. Law, who joined WesternU in July 1999, earned her bachelor’s degree in pharmacy from the University of Mumbai, India and her Master of Science in Pharmaceutics and Ph.D. in Pharmaceutical Administration degrees from The Ohio State University. Dr. Law formerly served as the College’s Pharmacy Practice and Administration Department Chair from 2007 to 2018. She has served on AACP’s Board of Directors as elected Chair of Council of Faculties from 2015 to 2018. Dr. Law maintains an active research profile focused on practice and payment transformation, health outcomes measurement, and pharmacist roles in improving medication use outcomes. She has several grants, more than 80 peer-reviewed articles, >100 peer-reviewed abstracts and eight book chapters in her areas of interest and several invited talks across the globe. Dr. Law directs an ACCP peer-reviewed Health Outcomes Research fellowship, which has graduated nine fellows since 2003. She was recognized for her sustained and significant research contributions by her University’s Provost’s Distinguished Scholar Award in 2022; and by APhA with a Research in Pharmaceutical Sciences Award in 2023. Dr. Law’s teaching includes a Health Systems module, a course in Practice Management, a four-year longitudinal leadership curriculum, and a Stress Management elective involving Meditation, Mindfulness and Yoga. She also runs a telehealth center for the College in a value-based model. In addition to being active in AACP, APhA, ISPOR and CPhA, Dr. Law serves on 2 Editorial Advisory Boards and as an Associate Editor for RSAP. Dr. Law belongs to Rho Chi and Phi Lambda Sigma, was named fellow of APhA in 2013 and is a graduate of ALFP 2010. She is also actively engaged with her local community and heads an NGO focused on improving quality of life for senior citizens.

Dr. Alexander Morris-Wood is a nationally recognized leader in neuroinclusive education and currently serves as Head of School at Franklin Academy in Connecticut. He has dedicated his career to advancing systemic models that integrate academic rigor, executive functioning development, and college readiness for neurodivergent learners. Previously, he served as Vice President of Program Development and Dean of Admissions at Beacon College, where he founded the Center for College Readiness and developed the Triadic Model, a cross-divisional framework aligning admissions, academics, and student support to improve retention and student success. Dr. Morris-Wood’s research examines family systems theory and the emotional impact on parents when their autistic child transitions to higher education. He now consults with colleges and universities nationwide on implementing institution-wide neuroinclusive practices and launched the Center for Neurodiversity, a regional initiative expanding access and professional capacity to support neurodivergent individuals and their families.

James Fraser studied Biology as an undergraduate at McGill University. His Ph.D. work at UC Berkeley under Dr. Tom Alber focused on the relationship between protein conformational dynamics and enzymatic catalysis. He moved to UCSF to start his lab in 2011. Currently, Professor Fraser is Chair of the Department of Bioengineering and Therapeutic Sciences. His lab’s work spans across various disciplines, including structural biology, deep mutational scanning, and drug discovery. He is also known for his commitment to open science, serving on the board of ASAPbio for many years. He recently started OpenADMET, an organization with the mission to build open predictive models of drug safety and toxicity to more reliably, cheaply, and effectively treat disease.